share_log

Coya Therapeutics, Inc. Highlights Publication Of An Article Titled 'Ex Vivo Expanded Human Regulatory T Cells Modify Neuroinflammation in a Preclinical Model of Alzheimer's Disease'

Benzinga Real-time News ·  Jan 26, 2023 09:05
Coya Therapeutics, Inc. Highlights Publication Of An Article Titled 'Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer's Disease'
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment